Tolerability and safety of topiramate in Chinese patients with epilepsy: An open-label, long-term, prospective study

Clinical Drug Investigation

Volumn 27, Issue 10, 2007, Pages 683-690

  Lu, Yang ^a   Wang, Xuefeng ^a   Li, Qihua ^b   Li, Jingmei ^a   Yan, Yong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Department of Neurology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADOLESCENT; ADULT; ANHIDROSIS; ANOREXIA; ARTICLE; ATAXIA; BLOOD ANALYSIS; CHILD; CHINESE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; COMBINATION CHEMOTHERAPY; DESQUAMATION; DIZZINESS; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FIXED DRUG ERUPTION; FOCAL EPILEPSY; GRAND MAL SEIZURE; HEADACHE; HUMAN; KIDNEY FUNCTION TEST; LEARNING DISORDER; LIVER FUNCTION TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; MONOTHERAPY; MYOPIA; NEPHROLITHIASIS; NYSTAGMUS; OPEN STUDY; PAPULE; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PRURITUS; RASH; RESPONSE TIME; SIDE EFFECT; SKIN MANIFESTATION; SOMNOLENCE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHINA; DIZZINESS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY DISORDERS; PARESTHESIA; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 34748862542     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200727100-00003     Document Type: Article

References (21)

1. Van Passel L, Arif H, Hirsch LJ. Topiramate for the treatment of epilepsy and other nervous system disorders. Expert Rev Neurother 2006; 6 (1): 19-31
2. Guerrini R, Parmeggiani L. Topiramate and its clinical applications in epilepsy. Expert Opin Pharmacother 2006; 7 (6): 811-23
3. Glauser TA. Topiramate. Epilepsia 1999; 40 Suppl. 5: 71-80
4. Liao WP, Yang SQ, Yi YH, et al. An open-label study of topiramate as add-on therapy for epilepsy using slow titration. Neurology Asia 2005; 10: 99-104
5. Yen DJ, Yu HY, Guo YC, et al. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy. Epilepsia 2000; 41 (9): 1162-6
6. Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22 (4): 485-501
7. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology 2004; 111 (1): 109-11
8. Perez-Alvarez F, Timoneda-Gallart C, Baus-Rosell J. Topiramate and epilepsy in the light of Das-Naglieri Cognitive Assessment System. Rev Neurol 2006; 42 (1): 3-7
9. Froscher W, Schier KR, Hoffmann M, et al. Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy. Epileptic Disord 2005; 7 (3): 237-48
10. Grosso S, Franzoni E, Iannetti P, et al. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study. J Child Neurol 2005; 20 (11): 893-7
11. Silberstein SD, Neto W, Schmitt J, et al. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004; 61 (4): 490-5
12. Gilliam FG, Veloso F, Bomhof MA, et al. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003; 60 (2): 196-202
13. Lee S, Sziklas V, Andermann F, et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 2003; 44 (3): 339-47
14. Chang D, Shear N. Cutaneous reactions to anticonvulsants. Semin Neurol 1992; 12 (4): 329-37
15. Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998; 39 Suppl. 7: S3-7
16. Stephen LJ, Sills GJ, Brodie MJ. Topiramate in refractory epilepsy: a prospective observational study. Eplepsia 2000; 41 (8): 977-80
17. Wang XF, Shen DL. Drug-tolerability of carbamazepine, phenobarbital and phenytoin in Chinese patients with epilepsy [in Chinese]. Lin Chuang Shen Jing Bing Xue Za Zhi 1993; 6 (4): 226-7
18. Wang XF, Shen DL. The tolerable and intolerable side effects of valproic acid in Chinese patients with epilepsy [in Chinese]. Xin Yao Yu Lin Chuang 1993; 12 (5): 289-90
19. Korean Topiramate Study Group. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Epilepsia 1999; 40 (12): 1767-74
20. Ong LC, Ali S, Muhammad Ismail HI. An open label trial of topiramate as add-on therapy for Malaysian children with inadequately controlled epilepsy. Neurol J Southeast Asia 2003; 8: 97-102
21. Garnett WR. Clinical pharmacology of topiramate: a review. Epilepsia 2000; 41 Suppl. 1: 61-5